Premier Inc - Company Profile
Powered by
All the data and insights you need on Premier Inc in one report.
- Save hours of research time and resources with
our up-to-date Premier Inc Strategy Report
- Understand Premier Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
Business Description
Premier Inc (Premier) is a healthcare improvement company, which is an alliance of several hospitals and other providers in the US. The company offers an integrated platform of solutions that addresses total cost management, quality and safety improvement and population health management. The company operates through two reportable business segments: Supply Chain Services and Performance Services.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
The company’s research and development (R&D) efforts focus on developing internal software, development of proprietary technology, enhancing products offerings and new product in the areas of cost management, quality and safety and value-based care. In FY2022, Premier spent US$4.1 million on R&D, which as a percentage of sales stood at 0.3% and grew 24.4% YoY.
Business Segments
Overview
- It develops an integrated platform called PINC AI technology platform which delivers accurate and evidence-based results that are integrated with most EMR systems, which means customers can improve their quality of care and slash their healthcare costs faster than ever before. –Its Contigo Health provides third-party administrator services and management of health benefit programmes that allow employers to contract directly with healthcare providers. Employers can also access a specialised care network through Contigo Health's centres of excellence programme. - The company's digital invoicing and payables division, Remitra, provides financial support services to healthcare product and service suppliers. - In FY2022, the segment's capital expenditure stood at US$51.3 million, which decreased 28.8% YoY.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
- It includes Premier’s group purchasing organization program (GPO), specialty pharmacy offerings, and direct sourcing activities. The segment assists the company’s members in managing their non-labor expense categories through a combination of products, services and technologies. - It also provides members access to certain SaaS informatics products related to the supply chain and the opportunity to participate in its ASCEND and SURPASS collaborative. - Key products and solutions include group purchasing, specialty pharmacy, direct sourcing, SaaS informatics products and ASCEND collaborative. - It also offers specialty pharmacy business and provides traditional pharmacy dispensing services. - Premier also provides its members access to PremierConnect Supply Chain and its associated applications. Through its ASCEND Collaborative, members receive information about group purchasing programs, tiers and prices, and benchmarking metrics to assist them in identifying additional supply chain and operations’ cost-saving opportunities and knowledge sharing with other member participants and industry experts. - Its SURPASS Collaborative has been built upon and complements existing ASCEND Collaborative that enables even greater savings for members. It brings clinically led cohorts together to make decisions based on evidence about clinician and physician preference items with the goal of reducing the total cost of care materially. - The segment also has STOCKD, an E-Commerce platform, which is a part of multi-channel supply chain strategy. - The PROVIDEGX program is the company's effort to help facilitate the availability of drugs and other high-quality products to tackle supply challenges. - In FY2022, the segment's capital expenditure stood at US$29.7 million.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward